Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved.
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy / Maron, B.j., Spirito, P., Shen, W.k., Haas, T.s., Formisano, F., Link, M.s., Epstein, A.e., Almquist, A.k., Daubert, J.p., Lawrenz, T., Boriani, G., Estes Na, 3., Favale, S., Piccininno, M., Winters, S.l., Santini, M., Betocchi, S., Arribas, F., Sherrid, M.v., Buja, G., et al.. - In: JAMA. - ISSN 0098-7484. - 298:4(2007), pp. 405-412. [10.1001/jama.298.4.405]
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
BORIANI, Giuseppe;
2007
Abstract
Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
